Claudio G Brunstein

11PUBLICATIONS

41CO-AUTHORS

Gene and molecular therapyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 09, 2026

Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial.

|Sep 18, 2025

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.

Stephanie J Lee, Brent Logan, Mary M Horowitz

|Aug 01, 2025

Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.

Victoria Stepanyants, Hong Li, Danielle Cenin

|May 01, 2025

Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy.

Joseph M Farinella, Claudio G Brunstein

|Apr 02, 2025

Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation.

D P Nurse, H Li, D Cenin

|Jun 23, 2023

Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.

Betty K Hamilton, Lisa A Rybicki, Hong Li

Pageof 2

Frequent Collaborators

Daniel J Weisdorf

Najla El Jurdi

Grigori Okoev

Betty K Hamilton

Margaret L MacMillan

Michael R Grunwald

LaQuisa Hill

Aaron T Gerds

Robert M Dean

Jason G Dehn

Frequent Collaborators

Daniel J Weisdorf

Najla El Jurdi

Grigori Okoev

Betty K Hamilton